Pogorzelski, M., Hilser, T., Ting, S. C., Kansy, B., Gauler, T. C., Stuschke, M., . . . Kasper, S. (2021, May). Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab. Frontiers in Oncology.
Chicago Style (17th ed.) CitationPogorzelski, Michael, et al. "Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab." Frontiers in Oncology May. 2021.
MLA引文Pogorzelski, Michael, et al. "Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab." Frontiers in Oncology, May. 2021.